# Construction and Clinical Translation of ACE Targeted Nuclear Medicine Imaging Probe

> **NCT06203119** · — · RECRUITING · sponsor: **Peking University Cancer Hospital & Institute** · enrollment: 20 (estimated)

## Conditions studied

- Cancer

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT06203119
- **Lead sponsor:** Peking University Cancer Hospital & Institute
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2022-10-01
- **Primary completion:** 2024-10
- **Final completion:** 2024-10
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2024-08-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06203119

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06203119, "Construction and Clinical Translation of ACE Targeted Nuclear Medicine Imaging Probe". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06203119. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*